Ready to use diclofenac stick packs

1. An oral liquid diclofenac formulation comprising:

a) a therapeutically effective amount of diclofenac or a pharmaceutically acceptable salt thereof;

b) from about 0.05% to about 9% of an alkalizing agent; and

c) a sugar-based aqueous means for solubilizing and stabilizing the formulation, wherein the pH is from about 7 to about 10.

2. The formulation of claim 1 , wherein the alkalizing agent is selected from the group consisting of ammonia solution, ammonium carbonate, diethanolamine, monoethanolamine, potassium hydroxide, sodium borate, sodium carbonate, sodium bicarbonate, sodium hydroxide, triethanolamine, and trolamine.

3. The formulation of claim 1 , wherein the alkalizing agent is bicarbonate.

4. The formulation of claim 3 , wherein the alkalizing agent is potassium bicarbonate.

5. The formulation of claim 1 , wherein the diclofenac is diclofenac potassium.

6. The formulation of claim 1 , comprising about 50 mg of diclofenac or a pharmaceutically acceptable salt thereof in from about 8 g to about 25 g of the formulation.

7. The formulation of claim 1 , comprising from about 0.1% to about 1% diclofenac or a pharmaceutically acceptable salt thereof.

8. The formulation of claim 1 , wherein the diclofenac is present as diclofenac potassium and the bicarbonate is present as potassium bicarbonate.

9. The formulation of claim 1 , wherein the sugar-based aqueous means for solubilizing and stabilizing the formulation comprises a sugar selected from the group consisting of mono-, di-, tri-, and tetra-saccharides and sugar alcohols and combinations thereof.

10. The formulation of claim 9 , wherein the sugar-based aqueous means for solubilizing and stabilizing the formulation comprises;

a) a sugar selected from the group consisting of glucose, fructose, and galactose; or

b) sugar alcohols selected from the group consisting of ethylene, propylene glycol, glycerol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, sorbitol, galactitol, fucitol, iditol, inositol, volemitol, isomalt, maltitol, lactitol, maltotriitol, maltotetraitol and polyglycitol; or

c) a combination thereof.

11. The formulation of claim 1 , further comprising a flavoring agent, wherein the flavoring agent is selected from the group consisting of acacia syrup, acesulfame K, alitame, anise, apple, aspartame, banana, Bavarian cream, berry, black currant, butterscotch, calcium citrate, camphor, caramel, cherry, cherry cream, chocolate, cinnamon, bubble gum, citrus, citrus punch, citrus cream, cotton candy, cocoa, cola, cool cherry, cool citrus, cyclamate, cylamate, dextrose, eucalyptus, eugenol, fructose, fruit punch, ginger, glycyrrhetinate, glycyrrhiza (licorice) syrup, grape, grapefruit, honey, isomalt, lemon, lime, lemon cream, monoammonium glyrrhizinate, maltol, mannitol, maple, marshmallow, menthol, mint cream, mixed berry, neohesperidine DC, neotame, orange, pear, peach, peppermint, peppermint cream, raspberry, root beer, rum, saccharin, safrole, sorbitol, spearmint, spearmint cream, strawberry, strawberry cream, stevia, sucralose, sucrose, sodium saccharin, saccharin, aspartame, neotame, acesulfame potassium, mannitol, talin, xylitol, sucralose, sorbitol, swiss cream, tagatose, tangerine, thaumatin, tutti fruitti, vanilla, walnut, watermelon, wild cherry, wintergreen, xylitol, and mixtures thereof.

12. The formulation of claim 1 , comprising from about 95% to about 99.85% of the sugar-based aqueous means for solubilizing and stabilizing the formulation.

13. The formulation of claim 12 , wherein the sugar-based means for solubilizing and stabilizing the formulation comprises:

a) from about 0% to about 95% water; and

b) from about 5% to about 95% of a sugar or sugar alcohol or a combination thereof.

14. The formulation of claim 13 , wherein the sugar or sugar alcohol or combination thereof comprises:

a) from about 10% to about 90% sorbitol; and

b) from about 10% to about 90% of xylitol, maltitol, glycerol, fructose, erythritol or a combination thereof.

15. The formulation of claim 1 , wherein the sugar-based aqueous means for solubilizing and stabilizing the formulation comprises:

a) from about 0% to about 40% water; and

b) from about 60% to about 80% of a sugar or sugar alcohol or a combination thereof comprising:

i) from about 10% to about 90% sorbitol; and

ii) from about 10% to about 90% of xylitol, maltitol, glycerol, fructose, erythritol or a combination thereof.

16. The formulation of claim 1 , wherein the sugar-based aqueous means for solubilizing and stabilizing the formulation comprises:

a) from about 0% to about 60% water; and

b) from about 40% to about 90% of sorbitol, xylitol, maltitol, glycerol, fructose, erythritol or a combination thereof.

17. The formulation of claim 1 , wherein the sugar-based aqueous means for solubilizing and stabilizing the formulation comprises:

a) from about 0% to about 75% water; and

b) from about 25% to about 75% of xylitol.

18. The formulation of claim 1 , wherein the sugar-based aqueous means for solubilizing and stabilizing the formulation comprises:

a) from about 0% to about 75% water; and

b) from about 25% to about 75% of maltitol.

19. The formulation of claim 1 , wherein the sugar-based aqueous means for solubilizing and stabilizing the formulation comprises:

a) from about 0% to about 75% water; and

b) from about 25% to about 75% of glycerol.

20. The formulation of claim 1 , wherein the sugar-based aqueous means for solubilizing and stabilizing the formulation comprises:

a) from about 0% to about 75% water; and

b) from about 25% to about 75% of fructose.

21. The formulation of claim 1 , wherein the sugar-based aqueous means for solubilizing and stabilizing the formulation comprises:

a) from about 0% to about 85% water; and

b) from about 15% to about 45% of erythritol.

22. The formulation of claim 1 , having a density of from about 1.02 to about 1.5 g/ml.

23. The formulation of claim 1 , wherein the formulation comprises from about 25% to about 90% non-crystallizing sorbitol.

24. A method of treating a condition selected from pain and migraine in a patient in need thereof comprising administering to the patient a therapeutically effective amount of the formulation of claim 1 .

25. A method of treating pain or migraine in a patient in need thereof comprising administering to the patient a therapeutically effective amount of the formulation of claim 8 .